Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  • Rossella Talotta, University Hospital "Gaetano Martino"
  • ,
  • Fabiola Atzeni, University Hospital "Gaetano Martino"
  • ,
  • Magdalena Janina Laska

The pathogenesis of systemic lupus erythematosus (SLE) is characterised by the hyper-activation of immunologic pathways related to the antiviral response. Exogenous and endogenous retroviruses, by integrating their DNA templates in the host cell genome, may epigenetically control the transcription of genes involved in the immune response. Furthermore, their nucleic acids or neo-synthesized proteins could stimulate the sensor molecules placed upstream the inflammatory cascade. Exogenous retroviruses, like human immunodeficiency virus, have been associated to SLE-like manifestations or to a fair SLE diagnosis. In addition, there is some evidence confirming a pathogenic role of human endogenous retroviruses in SLE. In line with these data, the use of antiretroviral agents could represent an attractive opportunity in the future therapeutic algorithms of this disease, but studies are still missing.

Original languageEnglish
JournalAutoimmunity
Volume53
Issue4
Pages (from-to)177-191
Number of pages15
ISSN0891-6934
DOIs
Publication statusPublished - Jun 2020

    Research areas

  • antiretroviral therapy, human endogenous retroviruses, human immunodeficiency virus, retroviruses, Systemic lupus erythematosus, DNA METHYLATION, AICARDI-GOUTIERES SYNDROME, REVERSE-TRANSCRIPTASE, RHEUMATIC MANIFESTATIONS, HUMAN-IMMUNODEFICIENCY-VIRUS, HUMAN ENDOGENOUS RETROVIRUS, I INTERFERON, HERV-K, T-LYMPHOTROPIC VIRUS, ACTIVE ANTIRETROVIRAL THERAPY

See relations at Aarhus University Citationformats

ID: 186541558